Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
Antivasoproliferative therapy is a revolutionary trend in the treatment of neovascular age-related macular degeneration (nAMD), as it is aimed at blocking growth factors of the newly formed vessels. Currently, two anti-VEGF drugs are registered for ophthalmological use, and the search for new molecu...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2019-06-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/279 |